Fontan
8
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
50%
4 trials in Phase 3/4
100%
3 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
Cholate Clearance in Fontan and Heart Failure
Nitrate Effect on Exercise Capacitance
TRPV2 Agonists in the Fontan Circulation
Effect of Carvedilol on Exercise Performance in Fontan Patients
Canadian Adult Congenital Heart Disease Intervention Registry
Effects of Pulmonary Vasodilation Upon VA Coupling in Fontan Patients